Literature DB >> 4589641

A comparison of haloperidol with methadone in blocking heroin-withdrawal symptoms. A pilot study.

J Karkalas, H Lal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4589641     DOI: 10.1159/000468001

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN: 0020-8272


× No keyword cloud information.
  6 in total

1.  Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol.

Authors:  S K Puri; H Lal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Potential benefits of quetiapine in the treatment of substance dependence disorders.

Authors:  S Pirzada Sattar; Subhash C Bhatia; Frederick Petty
Journal:  J Psychiatry Neurosci       Date:  2004-11       Impact factor: 6.186

3.  Effects of cholinergic agonists and antagonists on morphine-withdrawal syndrome.

Authors:  M D Hynes; G Gianutsos; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

4.  The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.

Authors:  S G Zaluzny; G B Chesher; D M Jackson; R Malor
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

5.  Effectiveness and Safety of Haloperidol Add-on Methadone in Acute Opium Withdrawal Symptoms of Opioid-dependent Patients: A Double-blind Randomized Placebo-controlled Clinical Trial.

Authors:  Fattaneh Ghaderi-Bafti; Mehran Zarghami; Abdolkarim Ahmadi; Mahmood Moosazadeh; Pezhman Hadinezhad; Narjes Hendouei
Journal:  Addict Health       Date:  2021-04

6.  Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men.

Authors:  Ehsan Shokri-Kojori; Gene-Jack Wang; Nora D Volkow
Journal:  Transl Psychiatry       Date:  2021-09-01       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.